HOUSTON, Oct. 24, 2017 -- Sharps Compliance, Inc. (Nasdaq:SMED) announces that the company has properly disposed of more than 2 million pounds of unused medications since 2009. This milestone coincides with the Drug Enforcement Administration’s 14th “National Prescription Drug Take Back Day” on October 28, 2017, which Sharps Compliance supports. This event happens every April and October in local communities throughout the country. Sharps Compliance is committed to helping communities and citizens dispose of unused medications to combat the growing epidemic of prescription drug abuse and accidental poisonings throughout the year.
Photos accompanying this announcement are available at
http://www.globenewswire.com/NewsRoom/AttachmentNg/08e5302c-d1ac-4b93-bef1-de41fe0614df
http://www.globenewswire.com/NewsRoom/AttachmentNg/72704ddb-7856-465f-a8ef-ddca742f5dec
Sharps Compliance, a nationwide provider of management services for medical waste and unused medication, offers the MedSafe® and TakeAway Recovery System™ Envelopes designed for the safe, convenient, and proper disposal of opioid painkillers and other unused medications. Since 2009, Sharps’ solutions have facilitated the proper destruction of more than 2 million pounds of unused medications.
According to the Centers for Disease Control and Prevention, “More than 300,000 Americans have lost their lives to opioids—prescription and illicit—since 2000. In 2013, prescription opioid dependence, abuse, and overdose cost the United States $78.5 billion.”
MedSafe is an ultimate-user unused medication collection and disposal system. This easy-to-operate system accepts controlled (Schedules II-V), non-controlled, and over-the-counter medicines. The patent-pending MedSafe medication disposal program operates under, and is in compliance with, the October 2014 DEA rules and regulations.
MedSafe collection receptacles are located in retail pharmacies, long-term care facilities, hospitals and clinics with on-site pharmacies, law enforcement, government agencies, and narcotic treatment facilities.
“We are inundated almost every day with stories and coverage of the opioid abuse problem. It’s time we start focusing on, and creating awareness of, the solutions designed to address solving the problem,” said David P. Tusa, President and Chief Executive Officer of Sharps Compliance, Inc. “We believe facilitating the safe, convenient, and proper disposal of unused medications to be one of the key elements in successfully addressing the opioid issue. As a company, we continue to invest heavily in these solutions thereby furthering our commitment to take action against this growing crisis, which is responsible for an estimated 142 deaths per day in our country.”
Since the release of the updated DEA disposal regulations in 2014, Sharps Compliance has manufactured over 2,000 MedSafe collection receptacles. Customers have returned over 9,000 inner liners with nearly 400,000 pounds of unused medications.
The TakeAway Envelopes are available at participating pharmacies. Customers can simply purchase a USPS postage-paid TakeAway Envelope, put their unused medications in the envelope, and drop it in any mailbox. The TakeAway Envelope is specially designed for the proper disposal, transportation, and treatment of all drugs, including controlled substances. Local and federal governments, as well as the private sector, have stepped up to provide the envelopes to communities and citizens to help with medication disposal.
About Sharps Compliance, Inc.
Headquartered in Houston, Texas, Sharps Compliance is a leading full-service national provider of comprehensive waste management services, including medical, pharmaceutical, and hazardous. Its key markets include healthcare providers, assisted living/long-term care facilities, retail pharmacies and clinics, and the professional market which is comprised of physicians, surgery centers, dentists, and veterinary practices. Sharps also provides two simple solutions for safe and easy disposal of unused medications: MedSafe collection receptacles and TakeAway Medication Recovery System envelopes.
More information on Sharps Compliance and its products can be found on its website at www.sharpsinc.com.
| For more information contact: | ||
| Dennis Halligan Sharps Compliance Corp. Vice President of Marketing Phone: (713) 432-0300 Email: [email protected] | John Nesbett/Jennifer Belodeau Institutional Marketing Services (IMS) Phone: (203) 972-9200 Email: [email protected] |


FDA Limits Regulation of Wearable Devices and Wellness Software, Boosting Health Tech Industry
Nvidia Appoints Former Google Executive Alison Wagonfeld as First Chief Marketing Officer
Samsung Forecasts Strong Q4 Profit on AI-Driven Memory Chip Boom
Avelo Airlines to End DHS Deportation Flights and Close Arizona Base Amid Rising Costs
BlueScope Steel Shares Slip After Board Rejects A$13.2 Billion Takeover Bid
Discord Confidentially Files for U.S. IPO, Signaling Major Milestone
xAI Cash Burn Highlights the High Cost of Competing in Generative AI
GM Takes $6 Billion EV Write-Down as Electric Vehicle Demand Slows in the U.S.
OpenAI Sets $50 Billion Stock Grant Pool, Boosting Employee Equity and Valuation Outlook
Hanwha Ocean Shares Rise on Plans to Expand U.S. Shipbuilding Capacity
EU Orders Elon Musk’s X to Preserve Grok AI Data Amid Probe Into Illegal Content
FCC Exempts Select Foreign-Made Drones From U.S. Import Ban Until 2026
Embraer Boosts Aircraft Deliveries in Q4 2025, Signaling Strong Growth Into 2026
Lenovo Unveils AI Cloud Gigafactory With NVIDIA and Launches New AI Platform at CES 2026
Chevron Seeks Expanded U.S. License to Boost Venezuelan Oil Exports Amid Sanctions Talks
Baidu’s AI Chip Unit Kunlunxin Prepares for Hong Kong IPO to Raise Up to $2 Billion
Hyundai Motor Shares Surge on Nvidia Partnership Speculation 



